2型糖尿病、慢性腎臓病、フィネレノンと肺炎重症化、COVID-19有害事象減少の関係について調べた研究「Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease A FIDELITY Pooled Secondary Analysis」の結果が発表されました。

2型糖尿病、慢性腎臓病、フィネレノンと肺炎重症化、COVID-19有害事象減少の関係について調べた研究「Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease A FIDELITY Pooled Secondary Analysis」の結果が発表されました。
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797719
https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/jama/202211/577291.html

PAGETOP